Sphindile Magwaza¹*, Guido Van Hal¹ and Muhammad Hoque²

¹Social Epidemiology and Health Policy, University of Antwerp, Belgium
²Management College of Southern Africa, Durban-South Africa

*Corresponding Author: Sphindile Magwaza, Social Epidemiology and Health Policy, University of Antwerp, Belgium .

Received: April 29, 2022; Published: June 08, 2022

Abstract

Background: The study describes the views on colorectal cancer (CRC) burden and screening programmes from the perspectives of published authors located in Brazil and compare those with the South African perceptions as both countries are members of emerging economic partnership with China, India and Russia named “BRICS”.

Methods: A qualitative study was conducted using purposive sampling, targeting authors of published papers on CRC from peer-reviewed journals located in Brazil, that were identified through search engines including PubMED.gov, research gate, Academia and Web of Science. A SurveyMonkey was used and only nine participants from Brazil responded. Poor response rate was due the second wave of covid19 infection.

Results: Most participants from Brazil, agreed on the statement that CRC was one of the top five cancers in their country. Population based cancer registry are used as the main sources of data in Brazil. The factors affected CRC screening mentioned included a lack of CRC screening policy; high cost of CRC screening; country size limiting access to services; scarce resources; CRC as not a national priority; high demand placed from Universal Health Insurance and inaccessibility to private health care.

Conclusion: The study highlights multi-facet factors affecting access and effectiveness of CRC screening create opportunities for collaboration related to surveillance, demand creation; innovative screening methods and future research.

Keywords: Colorectal Cancer; Qualitative Interviews; Screening; Colonoscopy; Brazil

References

1. Sung H., et al. “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries”. CA: A Cancer Journal for Clinicians 71 (2021): 209-249.
2. Moura AR., et al. “Trends in the incidence and mortality of colorectal cancer in a brazilian city”. BMC Research Notes560 (2020).
3. Lambert R., et al. “Mass screening for colorectal cancer is not justified in most developing countries”. International Journal of Cancer2 (2009): 253-256.
4. Guimarães DP., et al. “The Performance of Colorectal Cancer Screening in Brazil: The First Two Years of the Implementation Program in Barretos Cancer Hospital”. Cancer Prevention Research (Phila) 2 (2021): 241-252.
5. Graham A., et al. “Estimating the incidence of colorectal cancer in Sub-Saharan Africa: A systematic analysis”. Journal of Global Health Science 2 (2012): 020404.
6. Bray F., et al. “Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries”. CA: A Cancer Journal for Clinicians 68 (2018): 394-424.
7. Magwaza S., et al. “National Cancer Control Plans: Comparative Analysis between South Africa and Brazil Focusing on Colorectal Cancer Control”. Journal of Gastrointestinal and Digestive System 10 (2016): 627.
8. Magwaza S., et al. “Service Providers and Researchers Perception on Colorectal Cancer Burden and Screening Programme in South Africa”. Journal of Community Medicine and Health Education 11 (2021): 717.
9. Polit DF and Beck CT. “Essentials of Nursing research”. Appraising evidence for nursing practice. 9^th edition”. Philadelphia: Wolters Kluwer (2018).
10. Perin DM., et al. “Providers' knowledge, attitudes, and practices related to colorectal cancer control in Brazil”. Preventive Medicine 81 (2015): 373-379.
11. Tong A., et al. “Consolidated Criteria for Reporting Qualitative Research: 32_item checklist for interviews and focus groups”. International Journal for Quality in Health Care 19 (2007): 349-357.
12. “Estimativa/2020. Incidência de Câncer no Brasil”. Rio de Janeiro: Ministério da Saúde (2019): 120.
13. Barbosa IR., et al. “Cancer mortality in Brazil”. Medicine16 (2015): e746.
14. Singh E., et al. “Establishment of a cancer surveillance programme: The South African experience”. Lancet Oncology8 (2015): e414-421.
15. Janz NK., et al. “Colorectal cancer screening attitudes and behavior: a population-based study”. Preventive Medicine 37 (2003): 627-634
16. Janz NK., et al. “Determinants of colorectal cancer screening use, attempts, and non-use”. Preventive Medicine 5 (2007): 452-428.
17. Marmot M. “Closing the Gap in a Generation: Health Equity through Action on the Social Determinants of Health, World Health Organization, Geneva (2008): 256.
18. Mehta SJ., et al. “Effect of Financial Incentives on Patient Use of Mailed Colorectal Cancer Screening Tests: A Randomized Clinical Trial”. JAMA (2019).
19. Levin TR., et al. “Effects of organized colorectal cancer screening on cancer incidence and mortality in a large community-based population”. Gastroenterology 155 (2018): 1383-1391.
20. Arnold M., et al. “Global patterns and trends in colorectal cancer incidence and mortality”. Gut 66 (2017): 683-691.
21. Anderson DW., et al. “Mobile colonoscopic surveillance provides quality care for hereditary nonpolyposis colorectal carcinoma families in South Africa”. Colorectal Disease 6 (2007): 509-514.
22. Bruwer Z., et al. “A mobile colonoscopic unit for lynch syndrome: trends in surveillance uptake and patient experiences of screening in a developing country”. Journal of Genetic Counseling (2013): 125-137.
23. Honein-Abou HGN., et al. “Systematic review and meta-study synthesis of qualitative studies evaluating facilitators and barriers to participation in colorectal cancer screening”. Cancer Epidemiology, Biomarkers and Prevention 25 (2016): 907-917.
24. Menees SB., et al. “Women patients’ preference for women physicians is a barrier to colon cancer screening”. Gastrointestinal Endoscopy 62 (2005): 219-223.
25. Ladabaum U., et al. “Strategies for Colorectal Cancer Screening”. Gastroenterology 158 (2020): 418-432.
26. Friedemann-Sa´nchez GGJ and Partin MR. “Gender differences in colorectal cancer screening barriers and information needs”. Health Expect 10 (2007): 148-160.
27. Green AR., et al. “Barriers to screening colonoscopy for low-income Latino and white patients in an urban community health centre”. Journal of General Internal Medicine 23 (2008): 834-840.
28. Fedewa SA., et al. “Elimination of cost-sharing and receipt of screening for colorectal and breast cancer”. Cancer 121 (2015): 3272-3280.
29. Fedeli U., et al. “Impact of faecal immunochemical test-based screening programs on proximal and distal colorectal cancer surgery rates: a natural multiple baseline experiment”. Cancer 121 (2015): 3982-3989.
30. De Moor JS., et al. “Colorectal cancer screening in the United States: trends from 2008 to 2015 and variation by health insurance coverage”. Preventive Medicine 112 (2018): 199-206.
31. Wong BC., et al. “Attitudes and knowledge of colorectal cancer and screening in Hong Kong: a population-based study”. Journal of Gastroenterology and Hepatology 21 (2006): 41-46.
32. McLachlan S-A., et al. “Patients’ experiences and reported barriers to colonoscopy in the screening context-A systematic review of the literature”. Patient Education and Counselling 86 (2012): 137-146.
33. Kimura A., et al. “Barriers and facilitators to colorectal cancer screening in Vietnamese Americans: a qualitative analysis”. Journal of Cancer Education 4 (2014): 728-734.
34. Doubeni C., et al. “Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study”. Gut 67 (2018): 291-298.
35. Hewitson PGP., et al. “Cochrane systematic review of colorectal cancer screening using the faecal occult blood test (haemoccult): an update”. The American Journal of Gastroenterology 103 (2009): 1541-1549.
36. Almog R., et al. “The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening”. European Journal of Cancer Prevention 5 (2008): 430-437.
37. Shokar NK., et al. “Cancer and colorectal cancer: knowledge, beliefs, and screening preferences of a diverse patient population”. Family Medicine 37 (2005): 341-347.
38. Teixeira C., et al. “Colorectal Cancer Screening: What Is the Population's Opinion”. GE - Portuguese Journal of Gastroenterology 2 (2018): 62-67.
39. Beeker C., et al. “Colorectal cancer screening in older men and women: qualitative research findings and implications for intervention”. Journal of Community Health 3 (2020): 263-278.
40. Beebe TJ., et al. “Assessing attitudes toward laxative preparation in colorectal cancer screening and effects on future testing: potential receptivity to computed tomographic colonography”. Mayo Clinic Proceedings 82 (2007): 666-671.
41. Brittain K and Murphy VP. “Socio-cultural and health correlates related to colorectal cancer screening adherence among urban African Americans”. Cancer Nursing 2 (2015): 118-124.
42. Teixeira CR., et al. “Clinical impact of the immunochemical fecal occult blood test for colorectal cancer screening in Brazil”. Annals of Gastroenterology 4 (2017): 442-445.
43. Zorzi M., et al. “Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test”. Gut 64 (2015): 784-790.
44. Denberg TD., et al. “Predictors of non-adherence to screening colonoscopy”. Journal of General Internal Medicine 20 (2005): 989-995.
45. Carrozzi G., et al. “Cancer screening uptake: association with individual characteristics, geographic distribution, and time trends in Italy”. Epidemiology Prevention 39 (2015): 9-18.
46. Adonis L., et al. “Predictors of adherence to screening guidelines for chronic diseases of lifestyle, cancers, and HIV in a health-insured population in South Africa”. Global Health Action (2014): 23807.
47. Adams LB., et al. “Medical Mistrust and Colorectal Cancer Screening Among African Americans”. Journal of Community Health 5 (2017): 1044-1061.
48. Liang PS., et al. “Adherence to competing strategies for colorectal cancer screening over 3 years”. The American Journal of Gastroenterology 111 (2016): 105-114.
49. Bass SB., et al. “Perceptions of colorectal cancer screening in urban African American clinic patients: differences by gender and screening status”. Journal of Cancer Education 1 (2011): 121-128.
50. Carethers J and Doubeni C. “Causes of Socioeconomic Disparities in Colorectal Cancer and Intervention Framework and Strategies”. Gastroenterology2 (2020).
51. , et al. “Cost‑effective interventions for breast cancer, cervical cancer, and colorectal cancer: new results from WHO‑CHOICE”. Cost Effectiveness and Resource Allocation 16 (2018): 38.
52. Melson JE., et al. “AGA White Paper: Roadmap for the Future of Colorectal Cancer Screening in the United States”. Clinical Gastroenterology and Hepatology 18 (2020): 2667-2678.
53. Malterud K., et al. “Sample Size in Qualitative Interview Studies: Guided by Information Power”. Qualitative Health Research 13 (2016): 1753-1760.
54. Tuckett A. “A qualitative research sampling-the very really complexities”. Nursing Research 12 (2004): 47-61.

Citation

Citation: Sphindile Magwaza., et al. “Colorectal Cancer Burden and Screening Practices in Brazil: A Qualitative Study on Perceptions from Published Authors". Acta Scientific Gastrointestinal Disorders 5.7 (2022): 03-11.

Copyright

Copyright: © 2022 Sphindile Magwaza., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.